Why Mass Spectrometry Matters for Peptide Research
High-performance liquid chromatography (HPLC) tells you how pure a peptide sample is — what fraction of the total material is the desired product. Mass spectrometry (MS) tells you what that product is — confirming molecular identity by measuring the molecular weight with high precision. These two analytical techniques are complementary and both are essential for quality assurance. A sample could be 99% pure by HPLC but consist entirely of the wrong peptide if the synthesis produced an incorrect sequence that happened to have similar chromatographic properties. Conversely, a sample could have the correct molecular weight but contain significant impurities. Only by combining HPLC purity data with MS identity confirmation can you be confident that your research material is both pure and correctly identified.
This guide explains the two most common mass spectrometry techniques used for peptide analysis — electrospray ionization (ESI-MS) and matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) — and provides practical guidance for interpreting the mass spectrometry data on your Certificate of Analysis.
Fundamental Principles of Mass Spectrometry
All mass spectrometers measure the mass-to-charge ratio (m/z) of ions. The sample must first be ionized (given an electrical charge), then the ions are separated based on their m/z values by a mass analyzer, and finally they are detected and their relative abundances recorded. The output is a mass spectrum: a plot of signal intensity versus m/z value, where each peak corresponds to an ion of a specific mass and charge state.
For peptides, the measured molecular weight is compared to the theoretical molecular weight calculated from the amino acid sequence. Agreement within 1 Da (dalton) for instruments with unit mass resolution, or within a few parts per million (ppm) for high-resolution instruments, confirms the identity of the peptide.
ESI-MS: Electrospray Ionization Mass Spectrometry
ESI-MS is the most widely used ionization technique for peptide analysis and is the method used for most MiPeptidos product characterization. In this technique, the peptide solution is sprayed through a charged capillary at atmospheric pressure. The spray produces a fine mist of charged droplets that progressively evaporate, eventually yielding gas-phase ions that enter the mass analyzer.
The key characteristic of ESI is that it produces multiply charged ions. A peptide with a molecular weight of 4000 Da, for example, will appear in the mass spectrum not as a single peak at m/z 4000, but as a series of peaks corresponding to different charge states: [M+2H]2+ (doubly charged, appearing at approximately m/z 2001), [M+3H]3+ (triply charged, appearing at approximately m/z 1334), [M+4H]4+ (quadruply charged, appearing at approximately m/z 1001), and so on. The 'H' refers to protons (hydrogen ions) added during ionization, and each proton adds both one unit of charge and approximately 1.008 Da of mass.
This multi-charging is advantageous because it brings high-mass ions into the optimal detection range (typically m/z 400–2000) of quadrupole and ion trap mass analyzers, which are less effective at very high m/z values. However, it means that raw ESI spectra must be mathematically deconvoluted to determine the intact molecular weight.
ESI-MS is directly compatible with liquid chromatography (LC-MS), allowing real-time mass measurement of compounds as they elute from an HPLC column. This combination of chromatographic separation with mass identification is exceptionally powerful for characterizing complex peptide mixtures.
Reading an ESI Mass Spectrum
Let us work through a practical example using semaglutide (theoretical MW 4113.64 Da).
The ESI spectrum would show a characteristic charge state envelope: [M+3H]3+ at approximately m/z 1372.2, [M+4H]4+ at approximately m/z 1029.4, [M+5H]5+ at approximately m/z 823.7, and potentially additional charge states. The most intense peak (the base peak) is typically the [M+3H]3+ or [M+4H]4+ ion for peptides in this mass range.
To calculate the intact molecular weight from any observed m/z value and its charge state: MW = (m/z x z) - (z x 1.008), where z is the number of charges (protons). For the [M+3H]3+ ion at m/z 1372.2: MW = (1372.2 x 3) - (3 x 1.008) = 4116.6 - 3.024 = 4113.6 Da, which matches the theoretical value of 4113.64 Da within the expected precision.
Modern software performs this deconvolution automatically, presenting a single 'deconvoluted' molecular weight calculated from all observed charge states. The deconvoluted MW should agree with the theoretical MW within the instrument's mass accuracy specification — typically within 1 Da for unit-resolution instruments or within 5 ppm for high-resolution instruments.
MALDI-TOF: Matrix-Assisted Laser Desorption/Ionization Time-of-Flight
MALDI-TOF is the second major mass spectrometry technique for peptide characterization. In this method, the peptide sample is mixed with a UV-absorbing matrix compound (commonly alpha-cyano-4-hydroxycinnamic acid or sinapinic acid) and co-crystallized on a metal sample plate. A pulsed UV laser (typically 337 nm nitrogen laser or 355 nm Nd:YAG laser) fires at the sample, causing the matrix to absorb the laser energy, sublimate, and carry analyte molecules into the gas phase as ions. The ions are then accelerated through a high-voltage field and enter a field-free flight tube, where they separate based on velocity: lighter ions travel faster and reach the detector before heavier ions.
Unlike ESI, MALDI predominantly produces singly charged ions [M+H]+ for peptides. This means the observed m/z value directly approximates the molecular weight (plus 1.008 Da for the added proton). MALDI spectra are therefore simpler to interpret than ESI spectra, with the main peak directly indicating the intact molecular weight.
MALDI-TOF offers several practical advantages: it is fast (spectra acquired in seconds), tolerant of salts and buffer components that would suppress ESI signal, requires minimal sample preparation, and consumes very little material. However, it generally provides lower mass accuracy and resolution than ESI-MS, and it is not directly compatible with online LC separation.
Reading a MALDI-TOF Spectrum
The primary peak in a MALDI spectrum is the [M+H]+ ion, appearing at approximately MW + 1.008. For BPC-157 (theoretical MW 1419.53 Da), the [M+H]+ peak would appear at approximately m/z 1420.5.
Common additional peaks include:
[M+Na]+ adduct at approximately [M+H]+ + 22 Da. Sodium adducts are ubiquitous in MALDI analysis because trace sodium from glassware, solvents, and the matrix is almost impossible to eliminate completely. A sodium adduct peak at +22 Da from the main peak is expected and is not a quality concern unless its intensity exceeds that of the [M+H]+ peak.
[M+K]+ adduct at approximately [M+H]+ + 38 Da. Potassium adducts are less common than sodium but follow the same principle. A small potassium adduct peak is normal.
[2M+H]+ dimer at approximately 2x MW + 1. This can appear when sample concentration is high and represents non-covalent dimerization during the MALDI process, not a structural feature of the peptide.
Identifying Quality Concerns in Mass Spectra
Mass spectrometry data can reveal several quality issues that may not be apparent from HPLC data alone.
Oxidation (+16 Da). A peak or shoulder at exactly +16 Da from the main peak indicates oxidation, most commonly of methionine (to methionine sulfoxide) or tryptophan. While trace oxidation may be acceptable, a significant +16 peak (more than 5% of the main peak intensity) indicates degradation that could affect biological activity.
Deamidation (+1 Da). Conversion of asparagine to aspartate adds exactly 1 Da. Detecting this requires high-resolution mass spectrometry because the mass shift is very small. Deamidation is common in peptides containing Asn-Gly sequences and accelerates under alkaline conditions.
Deletion peptides (-mass of one amino acid). Peaks at molecular weights corresponding to the target minus one amino acid indicate deletion impurities from incomplete coupling during synthesis. These are critical impurities because they may retain partial biological activity.
Unexpected masses. Peaks at molecular weights that do not correspond to any expected modification or fragment of the target peptide suggest contamination with an entirely different compound.
Interpreting COA Mass Spectrometry Data
Every MiPeptidos Certificate of Analysis includes mass spectrometry data with three key values: the observed (experimental) molecular weight, the theoretical (calculated) molecular weight, and the molecular formula. Confirm that the observed MW matches the theoretical MW within 1 Da. Larger discrepancies indicate incorrect identity or significant modification.
Additional elements to look for include the ionization method used (ESI or MALDI), the mass analyzer type (quadrupole, TOF, Orbitrap), and ideally an actual spectrum image showing peak shape and the absence of significant satellite peaks.
Red Flags in Mass Spectrometry Reports
Be cautious of mass differences exceeding 2 Da between observed and theoretical values. Multiple peaks of similar intensity in the spectrum (suggesting a mixture rather than a pure compound). Dominant peaks at unexpected masses. Significant +16 Da oxidation peaks. Missing mass spec data entirely — HPLC alone cannot confirm peptide identity. Mass spec data that appears to be copied from another product's COA.
Disclaimer
For educational purposes only. Not for human consumption.